Paragraph 41 Variation of marketing authorisation: national homoeopathic products
The fee payable under regulation 19(1) in connection with an application for a variation of a marketing authorisation in respect of a national homoeopathic product is—
F1£296 where the application is a standard variation application for a homoeopathic medicinal product;
F2£456 where the application is a new indication variation application; and
F3£149 for any other application.
Annotations
Textual amendments
- F1
Sum in Sch. 2 para. 41(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(16)(a)
- F2
Sum in Sch. 2 para. 41(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(16)(b)
- F3
Sum in Sch. 2 para. 41(c) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(16)(c)